Public Company

MAIA Biotechnology

Telomere targeting immunotherapies for cancer


MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.


Founded 2018
Type Public
Longevity related Yes
Location Chicago, Illinois, USA

Recent Jobs at MAIA Biotechnology

Latest News


MAIA $1.49 2.76% $0.04